BEBIG Isotopentechnik und Umweltdiagnostik

BEBIG Isotopentechnik und Umweltdiagnostik, now operating as Eckert & Ziegler BEBIG, is a leading European provider of brachytherapy products and services. The company specializes in the development and production of radioactive sources, such as Iodine-125 seeds and Cobalt-60 sources, used for the localized treatment of various cancers. Their portfolio includes permanent implants for prostate cancer and temporary high-dose-rate (HDR) afterloading systems for gynecological and other malignancies. Based in Berlin, the company leverages decades of expertise in isotope technology to serve the global oncology market. As a subsidiary of the Eckert & Ziegler Group, it maintains a strong focus on precision radiotherapy and clinical safety.